Argonne appoints Sean Jones as Deputy Laboratory Director
The U.S. Department of Energy’s Argonne National Laboratory has named Sean Jones as deputy laboratory director for science and technology. Jones will begin his new role on October 9, serving as Argonne’s senior science strategist, advisor, and chief research officer. Jones will join Argonne from the National Science Foundation (NSF). In his current role as Assistant […]
BetterUp enters into a partnership with Microsoft Viva
BetterUp®, the human transformation company, yesterday announced a partnership and integration with Microsoft Viva, the employee experience platform, to bring tools for personalized insights and performance improvement into the workplace. Starting next month, millions of Microsoft Viva users will have access to BetterUp through dynamic science-backed journeys designed to help people uncover greater purpose, performance, […]
Janux Therapeutics designates Zachariah McIver as Vice President, Clinical Development
Janux Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms, yesterday announced the appointment of Dr. Zachariah (“Zach”) McIver as Vice President, Clinical Development. An accomplished physician-scientist with more than 15 years […]
RQM+ takeovers Libra Medical
RQM+, one of the world’s leading MedTech service provider, yesterday announced the acquisition of Libra Medical, a full-service contract research organization (CRO) that specializes in early-stage clinical trials. Founded in 2007, Libra Medical provides regulatory affairs, clinical operations and quality assurance services to companies that develop complex medical devices and diagnostics products. Libra’s studies take […]
SARC welcomes Dr. Jonathan Fletcher as Chief Scientific Officer
SARC (Sarcoma Alliance for Research Through Collaboration) had recently announced to welcome Dr. Jonathan Fletcher, M.D., to been elected for latest role of Chief Scientific Officer (CSO). The firm is a non-profit cancer research organization powering out a collaborative discovery, translational research, clinical trials in sarcoma, a form of cancer that influences children, adults. Within […]
